Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19

Overview of attention for article published in Annals of Internal Medicine, January 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 20 news outlets
policy: 1 policy source
twitter: 122 X users

facebook: 2 Facebook pages
f1000: 1 research highlight platform

Readers on

mendeley: 196 Mendeley

So far, Altmetric has seen 134 X posts from 122 X users, with an upper bound of 626,988 followers.

@VPrasadMDMPH Same goes for our target trial emulation showing NO benefit for therapeutic anticoagulation in ICU patients. https://t.co/509oMKI6Y8

@drjohnm Our observational study/target trial emulation on therapeutic anticoagulation in ICU patients w/COVID-19, showing NO mortality benefit, confirmed by subsequent RCTs. https://t.co/509oMKqvzy

RT @AnnalsofIM: Congratulations Jr. Investigator Award recipient Hanny Al-Samkari, MD @HannyAlSamkari @harvardmed for 'Thrombosis, Bleeding…

Congratulations Jr. Investigator Award recipient Hanny Al-Samkari, MD @HannyAlSamkari @harvardmed for 'Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID19.' https://…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 130 additional X posts.